Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
18.18
+0.30 (1.68%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Innoviva Employees
Innoviva had 127 employees as of December 31, 2024. The number of employees increased by 15 or 13.39% compared to the previous year.
Employees
127
Change (1Y)
15
Growth (1Y)
13.39%
Revenue / Employee
$2,824,496
Profits / Employee
$184,189
Market Cap
1.14B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
INVA News
- 15 days ago - Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva - PRNewsWire
- 23 days ago - Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference - Business Wire
- 4 weeks ago - Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress - Business Wire
- 4 weeks ago - Innoviva: Underappreciated Strength In Hospital Therapeutics - Seeking Alpha
- 7 weeks ago - Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
- 3 months ago - Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole) - Business Wire
- 3 months ago - Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States - GlobeNewsWire
- 4 months ago - Innoviva to Participate in the Citi 2024 Global Healthcare Conference - Business Wire